A cellular protein whose normal function appears to suppress bone formation may be a potential new target for treating osteoporosis, suggests a collaborative study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
In the study, published July 29 in Nature Communications, investigators discovered that mice lacking the cellular protein SLITRK5, found on the surface of bone-forming osteoblast cells, built...